Lyngby, Denmark

Morten Bang Norgaard




Average Co-Inventor Count = 3.8

ph-index = 1


Location History:

  • Lyngby, DK (2008 - 2009)
  • Kgs. Lyngby, DK (2010)

Company Filing History:


Years Active: 2008-2010

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Morten Bang Norgaard: Pioneering Innovations in SSRIs

Introduction

Morten Bang Norgaard is an accomplished inventor based in Lyngby, Denmark, with a noteworthy portfolio of five patents. His contributions to the field of pharmaceuticals, particularly in the development of selective serotonin reuptake inhibitors (SSRIs), have significantly advanced treatment options for various mental health conditions.

Latest Patents

Norgaard's latest innovations include two key patents. The first, titled "2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIs," relates to compounds that show promise as SSRIs and includes pharmaceutical compositions comprising these compounds. The second patent, "2-(1H-indolylsulfanyl)-aryl amine derivatives," covers additional compounds of formula IV and their potential applications in medicine.

Career Highlights

Morten Bang Norgaard is currently associated with H. Lundbeck A/S, a global pharmaceutical company specializing in brain diseases. His work demonstrates a strong focus on innovative drug discovery aimed at improving mental health outcomes.

Collaborations

Throughout his career, Norgaard has collaborated with notable colleagues, including Jan Kehler and Karsten Juhl. Their joint efforts underscore the importance of teamwork in the research and development of new therapeutic compounds.

Conclusion

Morten Bang Norgaard's contributions to pharmaceuticals through his innovative patents reflect a significant impact on the field of SSRIs. His ongoing work at H. Lundbeck A/S, alongside esteemed colleagues, continues to push the boundaries of what is possible in mental health treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…